PwC’s Jo Pisani joins EPR advisory board
European Pharmaceutical Review welcomes the newest member of its Editorial Advisory Board
List view / Grid view
News
EMA grants marketing authorisation for Prevymis against cytomegalovirus
10 November 2017 | By
The EMA has recommended granting a marketing authorisation Prevymis, an antiviral medicine that prevents CMV reactivation and disease...
Ozanimod successful in clinical trials for multiple sclerosis
The findings from the two pivotal phase 3 trials pave the way for ozanimod to enter the New Drug Approval process with the FDA...
HPV vaccine found to prevent childhood respiratory papillomatosis
The vaccine that protects against cancer-causing types of human papillomavirus also prevents an uncommon but incurable childhood respiratory disease...
Nanoshells could deliver more chemo with fewer side effects
In vitro study verifies method for remotely triggering release of cancer drugs...
Vetter expands its footprint in Asia Pacific region
Company establishes its presence in South Korea...
NHS England partners with Merck allowing people with MS immediate access to cladribine
NHS England has announced a commercial agreement that allows patients in England immediate access to the innovative new multiple sclerosis treatment...
Fat cells may inactivate chemotherapeutic drug
A study has shown that Adipocytes can absorb and metabolise the chemotherapeutic agent daunorubicin, reducing its ability to kill cancer cells.
Dolomite Bio introduces the Nadia product family for single cell research
Dolomite Bio is delighted to announce the launch of the game-changing Nadia single cell platform, a groundbreaking system set to escalate scRNA-Seq to new heights, offering the fast-growing single cell research sector an innovative solution for a wide range of potential applications...
Gene breakthrough on lithium treatment for bipolar disorder
Genes linked to schizophrenia in psychiatric patients suffering from bipolar disorder are the reason why such patients don't respond to the drug lithium...
Combination analysis reveals effects of combining clinically used drugs
The effect of combining clinically used drugs for the treatment of colon cancer analysed using novel open source software...
Lab Innovations 2017 celebrates another triumph
At 4:00 pm on Thursday the 2nd of November, Lab Innovations celebrated the end of another extremely successful show at the NEC, Birmingham, UK, involving over 130 exhibitors and over 2,500 visitors...
Rap parody wins the MicroTAS video competition 2017
The MicroTAS Video Competition 2017, sponsored by Dolomite Microfluidics and Lab on a Chip, and supported by the Chemical and Biological Microsystems Society, saw first prize awarded to Anu Kaushik and Alex Trick, PhD candidates in the BioMEMS and Single Molecule Dynamics Lab at Johns Hopkins University in Baltimore, Maryland...
Tolvaptan identified as a treatment for autosomal dominant polycystic kidney disease
A phase 3 trial studying the effects of tolvaptan has found that the drug slowed the rate of decline in kidney function in patients with polycystic kidney disease...
FDA approves Zelboraf for certain patients with Erdheim-Chester disease
The FDA has expanded the approval of Zelboraf to include the treatment of certain adult patients with Erdheim-Chester Disease, a rare cancer of the blood...
